DE69737294D1 - Verfahren zur abtrennung des alpha-1-proteinase inhibitors von einer cohn-paste, welche die fraktionen iv-1 + iv-4 enthält - Google Patents

Verfahren zur abtrennung des alpha-1-proteinase inhibitors von einer cohn-paste, welche die fraktionen iv-1 + iv-4 enthält

Info

Publication number
DE69737294D1
DE69737294D1 DE69737294T DE69737294T DE69737294D1 DE 69737294 D1 DE69737294 D1 DE 69737294D1 DE 69737294 T DE69737294 T DE 69737294T DE 69737294 T DE69737294 T DE 69737294T DE 69737294 D1 DE69737294 D1 DE 69737294D1
Authority
DE
Germany
Prior art keywords
alpha
cohn
separating
paste containing
containing fractions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69737294T
Other languages
English (en)
Other versions
DE69737294T2 (de
Inventor
Sung Hwang
Evelyn Nario
Mark Lepe
Lyndon Luz
Hirokazu Ito
Kazuo Takechi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter Healthcare SA
Baxter International Inc
Original Assignee
Baxter Healthcare SA
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24701177&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69737294(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Healthcare SA, Baxter International Inc filed Critical Baxter Healthcare SA
Application granted granted Critical
Publication of DE69737294D1 publication Critical patent/DE69737294D1/de
Publication of DE69737294T2 publication Critical patent/DE69737294T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/811—Peptides or proteins is immobilized on, or in, an inorganic carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69737294T 1996-07-01 1997-06-27 Verfahren zur abtrennen von alpha-1-proteinase-inhibitor von cohn-fraktion iv1-iv4 paste Expired - Lifetime DE69737294T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US673064 1984-11-19
US08/673,064 US5616693A (en) 1996-07-01 1996-07-01 Process for seperating alpha-1-proteinase inhibitor from COHN IV1 +1V4 paste
PCT/US1997/011256 WO1998000154A1 (en) 1996-07-01 1997-06-27 Process for separating alpha-1-proteinase inhibitor from cohn fraction iv1 +iv4 paste

Publications (2)

Publication Number Publication Date
DE69737294D1 true DE69737294D1 (de) 2007-03-15
DE69737294T2 DE69737294T2 (de) 2007-07-12

Family

ID=24701177

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69739212T Expired - Lifetime DE69739212D1 (de) 1996-07-01 1997-06-27 Verfahren zur Trennung des alpha-1-Proteinaseinhibitors von Cohn-Fraktion IV1+IV4-Paste
DE69737294T Expired - Lifetime DE69737294T2 (de) 1996-07-01 1997-06-27 Verfahren zur abtrennen von alpha-1-proteinase-inhibitor von cohn-fraktion iv1-iv4 paste

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69739212T Expired - Lifetime DE69739212D1 (de) 1996-07-01 1997-06-27 Verfahren zur Trennung des alpha-1-Proteinaseinhibitors von Cohn-Fraktion IV1+IV4-Paste

Country Status (16)

Country Link
US (2) US5616693A (de)
EP (2) EP0944392B1 (de)
JP (3) JP4390855B2 (de)
KR (1) KR20000022480A (de)
AT (2) ATE420111T1 (de)
AU (1) AU726233B2 (de)
BR (1) BR9710107B1 (de)
CA (2) CA2259499C (de)
CZ (3) CZ300452B6 (de)
DE (2) DE69739212D1 (de)
DK (2) DK0944392T3 (de)
ES (2) ES2320919T3 (de)
IL (1) IL127774A (de)
PL (3) PL188874B1 (de)
PT (2) PT1762576E (de)
WO (1) WO1998000154A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616693A (en) * 1996-07-01 1997-04-01 Alpha Therapeutic Corporation Process for seperating alpha-1-proteinase inhibitor from COHN IV1 +1V4 paste
AU3731400A (en) * 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Methods and compositions useful in inhibiting apoptosis
WO2000051625A1 (en) * 1999-03-05 2000-09-08 The Trustees Of University Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of herpes viruses
WO2000051623A2 (en) 1999-03-05 2000-09-08 The Trustees Of University Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide-induced clinical conditions
US6849605B1 (en) * 1999-03-05 2005-02-01 The Trustees Of University Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of viral infections
US6462180B1 (en) 1999-11-24 2002-10-08 Bayer Corporation Method of preparing α-1 proteinase inhibitor
PT1343809E (pt) 2000-12-14 2015-09-22 Grifols Therapeutics Inc Método de preparação de inibidor de proteinase alfa-1
KR100406870B1 (ko) * 2001-05-25 2003-11-21 주식회사 두산 침전법을 이용한 계란 난황에서의 유용 수용성 성분의분리방법 및 침전 부산물의 이용 방법
AU2002331306A1 (en) * 2001-08-07 2003-02-24 Novozymes North America, Inc. Carbohydrates and polyols for dissolving protein crystals
CN100529066C (zh) * 2002-07-01 2009-08-19 诺维信公司 在发酵过程中加入单丙二醇
US7777006B2 (en) * 2002-12-31 2010-08-17 Csl Behring L.L.C. Method for purification of alpha-1-antitrypsin
US20040220242A1 (en) * 2003-05-02 2004-11-04 Leland Shapiro Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide induced clinical conditions
PL2520654T3 (pl) 2003-08-26 2017-08-31 The Regents Of The University Of Colorado, A Body Corporate Inhibitory aktywności proteazy serynowej i ich zastosowanie w sposobach i kompozycjach do leczenia zakażeń bakteryjnych
US7807435B2 (en) * 2005-08-11 2010-10-05 Baxter International Inc. Method for the purification of alpha-1 proteinase inhibitor (a1PI)
GB0524432D0 (en) * 2005-11-30 2006-01-11 Nhs Blood & Transplant Method
US20080124303A1 (en) * 2005-12-12 2008-05-29 Cavit Sciences, Inc Methods and compositions for treatment of viral infections
WO2007112953A1 (en) * 2006-03-30 2007-10-11 Baxter Internaional Inc. Process for the purification of recombinant alpha 1-antitrypsin involving a step of anion exchange chromatography
US8772240B2 (en) 2006-05-19 2014-07-08 Baxter International Inc. Ethanol dependence of alpha1 antitrypsin C-terminal lys truncation by basic carboxypeptidases
AU2012262428C1 (en) 2011-05-27 2018-10-11 Takeda Pharmaceutical Company Limited Therapeutic proteins with increased half-life and methods of preparing same
JP6216921B2 (ja) 2011-06-24 2017-11-01 ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド，ア ボディー コーポレイトＴＨＥ ＲＥＧＥＮＴＳ ＯＦ ＴＨＥ ＵＮＩＶＥＲＳＩＴＹ ＯＦ ＣＯＬＯＲＡＤＯ，ａ ｂｏｄｙ ｃｏｒｐｏｒａｔｅ アルファ−１抗トリプシン融合分子のための組成物、方法および使用
US10478508B2 (en) 2012-01-10 2019-11-19 The Regents Of The University Of Colorado, A Body Corporate Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
TWI629283B (zh) 2012-02-23 2018-07-11 巴克斯歐塔公司 來自血漿中的免疫球蛋白之ｉ-ｉｖ-１部分沉澱
US9353165B2 (en) 2012-07-25 2016-05-31 Grifols, S.A. Purification of cell culture derived alpha1 protease inhibitor
WO2014160768A1 (en) 2013-03-29 2014-10-02 The Regents Of The University Of Colorado Compositions and methods for preparing a subject for organ or non-organ implantation
IL267923B2 (en) 2018-08-02 2023-06-01 Grifols Worldwide Operations Ltd The composition containing the most concentrated alpha-1 type protein inhibitor and a method for obtaining it

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2770616A (en) * 1951-01-29 1956-11-13 Protein Foundation Inc Fractionation of proteinaceous materials in blood plasma and liver tissue
US2761808A (en) * 1952-09-06 1956-09-04 Ortho Pharma Corp Plasma fractionation process
US4056614A (en) * 1972-09-22 1977-11-01 Marc Bonneau Immunity depressant medicine
JPS52128205A (en) * 1976-04-16 1977-10-27 Green Cross Corp:The Prophylactic and therapeutic drugs for cerebro-vascular contraction
US4439358A (en) * 1982-06-17 1984-03-27 Miles Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US4379087A (en) * 1982-06-17 1983-04-05 Cutter Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
DE3426903A1 (de) * 1984-07-20 1986-01-23 Biotest Pharma GmbH, 6000 Frankfurt Eine immunglobulinpraeparation in kombination mit einer anderen pharmakologisch wirksamen praeparation zur verwendung bei der behandlung von krankheiten
US4684723A (en) * 1985-09-11 1987-08-04 Miles Laboratories, Inc. Method of separating proteins from aqueous solutions
US4697003A (en) * 1985-11-01 1987-09-29 Miles Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor
US4656254A (en) * 1985-12-02 1987-04-07 Miles Laboratories, Inc. Method of preparing alpha-1-proteinase inhibitor and antithrombin III
US4629567A (en) * 1986-03-07 1986-12-16 Smithkline-Rit Alpha-1-antiprotease purification
JPS6317899A (ja) * 1986-07-09 1988-01-25 Green Cross Corp:The ハプトグロビンの精製方法
JPS63132898A (ja) * 1986-11-26 1988-06-04 Meito Sangyo Kk 蛋白質の分離精製方法
US5093316A (en) * 1986-12-24 1992-03-03 John Lezdey Treatment of inflammation
US4829054A (en) * 1987-04-13 1989-05-09 Miles Laboratories, Inc. Method of decreasing lung damage in a host following the onset of gram negative septicemia/endotoxemia
EP0288841B1 (de) * 1987-04-27 1992-12-30 Miles Inc. Verfahren zur Herstellung von hochgereinigtem alpha-1-Proteinase-Inhibitor
IL86417A (en) * 1987-05-22 1992-09-06 Armour Pharma Process for the inactivation of pathogens in biological or pharmaceutical material by mixing with aqueous solution containing a sugar(alcohol)and neutral salts as stabilizers
US5073487A (en) * 1989-01-30 1991-12-17 Athens Research And Technology, Inc. Rapid assay for functional human α1 -proteinase inhibitor
FR2672895B1 (fr) * 1991-02-15 1995-05-12 Transgene Sa Procede de purification d'une proteine fortement glycosylee.
US6284874B1 (en) * 1994-06-17 2001-09-04 Alpha Therapeutic Corporation Process for separating α1-proteinase inhibitor from cohn fraction IV1 and IV4 paste
US5610285A (en) * 1994-08-24 1997-03-11 Bayer Corporation Purification of α-1 proteinase inhibitor using novel chromatographic separation conditions
US5616693A (en) * 1996-07-01 1997-04-01 Alpha Therapeutic Corporation Process for seperating alpha-1-proteinase inhibitor from COHN IV1 +1V4 paste

Also Published As

Publication number Publication date
EP0944392A4 (de) 2004-11-24
PL188830B1 (pl) 2005-04-29
DE69737294T2 (de) 2007-07-12
WO1998000154A1 (en) 1998-01-08
PL330934A1 (en) 1999-06-07
CZ300452B6 (cs) 2009-05-20
PT1762576E (pt) 2009-02-02
JP2009191076A (ja) 2009-08-27
AU3583197A (en) 1998-01-21
EP1762576A1 (de) 2007-03-14
BR9710107B1 (pt) 2009-05-05
AU726233B2 (en) 2000-11-02
PL188873B1 (pl) 2005-05-31
EP0944392A1 (de) 1999-09-29
ATE352569T1 (de) 2007-02-15
CZ302102B6 (cs) 2010-10-13
US5616693A (en) 1997-04-01
CZ301332B6 (cs) 2010-01-20
JP5245079B2 (ja) 2013-07-24
KR20000022480A (ko) 2000-04-25
IL127774A0 (en) 1999-10-28
ATE420111T1 (de) 2009-01-15
DK0944392T3 (da) 2007-04-23
CA2489773A1 (en) 1998-01-08
DK1762576T3 (da) 2009-04-20
JP2000514647A (ja) 2000-11-07
EP0944392B1 (de) 2007-01-24
ES2320919T3 (es) 2009-05-29
CA2259499C (en) 2006-01-24
US5981715A (en) 1999-11-09
CA2259499A1 (en) 1998-01-08
PL188874B1 (pl) 2005-05-31
JP4390855B2 (ja) 2009-12-24
IL127774A (en) 2005-08-31
ES2281104T3 (es) 2007-09-16
BR9710107A (pt) 1999-08-10
JP4588770B2 (ja) 2010-12-01
DE69739212D1 (de) 2009-02-26
JP2008120822A (ja) 2008-05-29
EP1762576B1 (de) 2009-01-07
CZ435698A3 (cs) 1999-05-12
PT944392E (pt) 2007-04-30

Similar Documents

Publication Publication Date Title
DE69737294D1 (de) Verfahren zur abtrennung des alpha-1-proteinase inhibitors von einer cohn-paste, welche die fraktionen iv-1 + iv-4 enthält
DE69818304D1 (de) Verfahren zur reduktion von oxiranyl-epothilonen zu olefinischen epothilonen
DE69535498D1 (de) Verfahren zur behandlung vaskulärer kopfschmerzen
DE69329300D1 (de) Verfahren zur Spaltung von Cumolhydroperoxid
ATE195503T1 (de) Verfahren zur destillation von alkoholen
DE69004353D1 (de) Verfahren zur Reinigung von Tryptophan.
DE59209268D1 (de) Verfahren zur thermochemisch-thermischen behandlung von einsatzstählen
DE69614824D1 (de) Verfahren zur herstellung von retrovial protease hemmenden zwischenprodukten
DE69829066D1 (de) Verfahren zur reinigung von alkanolaminen
ATE270275T1 (de) Verfahren zur herstellung von 2-aryl-3-aryl-5- halogen-pyridinen, verwendbar als cox-2 inhibitoren
DE69300901D1 (de) Verfahren zur Reinigung von 1,1,1,2-Tetrafluorethan.
DE69607559T2 (de) Verfahren zur Behandlung von Phenolteer
DE3852448D1 (de) Verfahren zur Aufarbeitung von Destillationsrückständen, die bei der Reinigung von Caprolactam anfallen.
DE69008201D1 (de) Verfahren zur Beseitigung von organischen Chlorverbindungen durch Verbrennung.
WO2001049665A3 (fr) Procede de purification de lactames
ATE173272T1 (de) Verfahren zur reaktivierung von gereinigten membranproteinen
DE59100288D1 (de) Verfahren zur aufarbeitung des sumpfproduktes von extraktivdestillationsprozessen zur gewinnung reiner aromaten.
ATE84041T1 (de) Verfahren zur herstellung von hochgereinigtem alpha-1-proteinase-inhibitor.
ATE283367T1 (de) Verfahren zur gewinnung von bakteriorhodopsin
ATE155481T1 (de) Verfahren zur reinigung von streptolysin 0, intaktes streptolysin 0 erhältlich nach diesem verfahren und seine verwendung
ATE79853T1 (de) Verfahren zur teilweisen reinigung eines oxyiodierungsproduktes.
DE59503639D1 (de) Verfahren zum chemischen modifizieren von alkylgruppenhaltigen flüssigkeiten
DE59100681D1 (de) Verfahren zur Reinigung von alpha-Bisabolol.
DE69726293D1 (de) Verfahren zur selektiven alkylierung von epoxyalkoholen

Legal Events

Date Code Title Description
8363 Opposition against the patent
8365 Fully valid after opposition proceedings